Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety
O Scholz(Deutsches Diabetes-Zentrum e.V.), Eckhard Lammert(Deutsches Diabetes-Zentrum e.V.), Haresh Ajani(Regional Centre of Advanced Technologies and Materials), Jens Hogeback, Michael Roden(Düsseldorf University Hospital), Anke Unger(Lead Discovery Center (Germany)), Elena Huß(Deutsches Diabetes-Zentrum e.V.), Miguel Sanz, Diran Herebıan(Heinrich Heine University Düsseldorf), Laura M. Levy, Silke Otter(Deutsches Diabetes-Zentrum e.V.), Stanimira Hristeva, Susanne Terheyden(Lead Discovery Center (Germany)), Alfredo Rodriguez Puentes, Michelle Reina do Fundo(Deutsches Diabetes-Zentrum e.V.), Anna B. Hamacher(Deutsches Diabetes-Zentrum e.V.), Torsten Hoffmann, Bedair Dewidar(Tanta University)
Cited by 2
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k